19.05.2026 • News

Alcami Completes Tjoapack Acquisition to Bolster Global Packaging Scale

Alcami completes its acquisition of Tjoapack, creating a 1,400-strong CDMO with over one million square feet of operations across the US and the Netherlands, adding European packaging scale and QP release services.

pharmaceutical vials
© Adobe Stock

Alcami, a US-based contract development and manufacturing organization (CDMO), recently announced the completion of the acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and the Netherlands.

The combined organization now employs over 1,400 skilled personnel across the US and the Netherlands. This expands the operational footprint to more than 1 million square feet and supports the production of over 80 commercial products worldwide. Alcami CEO & Chairman Patrick Walsh will assume the CEO responsibility of the combined organizations.

The combined companies are advancing planned integration activities to expand end-to-end CDMO capabilities across the US and Europe.  Tjoapack customers can expect uninterrupted service across all sites, while gaining access to Alcami’s broader portfolio of capabilities, including drug product manufacturing, laboratory services, and pharma storage. Alcami customers will benefit from expanded packaging scale, increased supply chain redundancy, and enhanced market access support, including Qualified Person (QP) release services in Europe. 

“This acquisition represents a meaningful step forward in Alcami’s long-term growth strategy to provide integrated global solutions for our clients”, said Chairman and CEO Patrick Walsh.  “We welcome the Tjoapack team and look forward to unlocking the full potential of our combined capabilities.” 

Company

Logo:

Alcami Corporation

4620 Creekstone Drive
27703 Durham
US

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.